How to Get Actos (Pioglitazone) in Colorado

Who Can Prescribe Pioglitazone in Colorado

Any Colorado-licensed clinician with prescriptive authority can write a pioglitazone prescription. That includes physicians (MD and DO), nurse practitioners (NPs), and physician assistants (PAs). Colorado grants NPs full practice authority under the Nurse Practice Act, meaning NPs do not need a collaborative agreement with a physician to prescribe pioglitazone independently [1].

PAs in Colorado prescribe under a collaborative agreement but retain broad formulary access that includes thiazolidinediones like pioglitazone. Primary care providers write the majority of pioglitazone prescriptions, though endocrinologists and hepatologists also prescribe it, particularly for off-label use in metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH). The PIVENS trial (N=247) demonstrated that pioglitazone 30 mg improved histological features of NASH in 34% of subjects versus 19% on placebo over 96 weeks [2]. That trial reshaped how hepatologists think about this drug.

If you do not have an existing relationship with a prescriber, a telehealth visit is the fastest path. Several national telehealth platforms serve Colorado patients, and HealthRX connects patients with providers who can evaluate candidacy, order baseline labs, and transmit an electronic prescription to the patient's chosen pharmacy.

Telehealth Access for Pioglitazone in Colorado

Colorado was among the first states to pass telehealth parity legislation. Senate Bill 17-212, effective since 2017, requires commercial insurers to cover telehealth services at the same rate as in-person visits [3]. This means a video consultation to obtain or renew a pioglitazone prescription carries no additional out-of-pocket cost compared to a clinic visit for patients with commercial insurance.

A typical telehealth workflow for pioglitazone takes 15 to 25 minutes. The prescriber reviews your medical history, confirms the indication (type 2 diabetes or off-label MASH), orders or reviews recent labs, and sends an e-prescription to your pharmacy. Colorado law permits prescribers to establish a patient-provider relationship via synchronous audio-video telemedicine, so a first-time prescription is fully legal through telehealth.

For patients in rural Colorado counties where endocrinology or hepatology access is limited, telehealth removes a real barrier. The Colorado Department of Regulatory Agencies (DORA) licenses all telehealth prescribers operating in the state, and you can verify any provider's license through the DORA online lookup tool. Ask for the prescriber's Colorado license number if you want to confirm credentials before your visit.

Required Labs Before Starting Pioglitazone

The FDA-approved prescribing information for pioglitazone mandates liver function testing before initiation [4]. Specifically, serum alanine aminotransferase (ALT) must be checked at baseline. Pioglitazone should not be started if ALT exceeds 2.5 times the upper limit of normal.

Here is what a standard pre-prescription lab panel looks like for pioglitazone in Colorado:

• ALT and AST: Required. Screens for pre-existing liver disease and establishes a baseline for monitoring.
• HbA1c: Standard for type 2 diabetes patients. Guides dosing decisions and documents the clinical indication.
• Fasting lipid panel: Recommended. Pioglitazone tends to raise HDL cholesterol and may increase LDL, a profile that differs from other thiazolidinediones [5].
• BNP or NT-proBNP: Considered in patients with heart failure risk. Pioglitazone carries an FDA black box warning for New York Heart Association (NYHA) Class III and IV heart failure [4].
• CBC: Optional but often bundled in metabolic workups.

Most Colorado patients can complete labs at Quest Diagnostics, Labcorp, or UCHealth laboratory locations. Telehealth providers frequently partner with national lab networks and can send standing orders electronically, so you can walk into a draw site without a separate appointment. Results typically return within 24 to 48 hours, and your prescriber can then authorize the pioglitazone prescription.

For patients being prescribed pioglitazone off-label for MASH, hepatologists may also request a FIB-4 score calculation or imaging (such as FibroScan or MRI-PDFF) to stage fibrosis. The AASLD practice guidance on NAFLD recommends pioglitazone as a pharmacotherapy option for biopsy-proven NASH with or without type 2 diabetes [6].

Pharmacy Options in Colorado

Pioglitazone is one of the most widely available generic diabetes medications in the United States. Every major retail pharmacy chain operating in Colorado stocks it. That includes Walgreens, CVS, King Soopers (Kroger), Safeway, Walmart, and Costco. Most pharmacies can fill a pioglitazone prescription the same day it is received electronically.

Generic pricing. Without insurance, 30 tablets of pioglitazone 30 mg typically cost between $4 and $30 at Colorado retail pharmacies. Walmart and Costco tend to offer the lowest cash prices. GoodRx and RxSaver discount cards can reduce the price further at participating locations. Brand-name Actos is significantly more expensive (often over $400 per month), but there is no clinical reason to use the brand when generics are bioequivalent.

Mail-order pharmacies. Colorado patients can use licensed mail-order pharmacies such as Amazon Pharmacy, Mark Cuban Cost Plus Drug Company, and Express Scripts. Cost Plus lists pioglitazone 30 mg at $4.20 for a 30-day supply, making it one of the cheapest options available. Shipping adds 3 to 7 business days.

503A compounding pharmacies. Colorado licenses 503A compounding pharmacies through the State Board of Pharmacy. These pharmacies can compound pioglitazone into alternative dosage forms (such as suspensions for patients with swallowing difficulties) if a prescriber writes a patient-specific prescription. They cannot produce and distribute large batches without individual prescriptions. If you need a compounded formulation, confirm that the pharmacy holds a current Colorado Board of Pharmacy compounding license.

Colorado Medicaid and Insurance Coverage

Colorado Medicaid (Health First Colorado) does not currently list pioglitazone on its preferred drug list for the type 2 diabetes indication [7]. Patients enrolled in Medicaid who need pioglitazone will face one of three options: obtain prior authorization (which may be denied), switch to a Medicaid-preferred agent such as metformin or a sulfonylurea, or pay cash out of pocket.

The cash-pay route is surprisingly viable given the low generic cost. At $4 to $10 per month through discount programs, pioglitazone is cheaper than many Medicaid copays for preferred drugs.

Commercial insurance. Most commercial plans in Colorado cover generic pioglitazone on Tier 1 or Tier 2 of their formulary. Copays typically range from $0 to $15 per month. Plans sold through Connect for Health Colorado (the state ACA marketplace) generally include pioglitazone, though formulary placement varies by carrier. Check your plan's formulary or call the number on the back of your insurance card.

Medicare Part D. Generic pioglitazone is covered by virtually all Medicare Part D plans. Under the Inflation Reduction Act provisions that took effect in 2025, Medicare beneficiaries pay no more than $2,000 annually across all covered prescription drugs, though pioglitazone's low cost means it rarely contributes meaningfully to that cap [8].

Prior authorization tips. When prior authorization is required (primarily for Medicaid or certain restrictive commercial plans), the insurer typically requests: a documented diagnosis of type 2 diabetes mellitus (ICD-10 E11.xx), evidence that first-line therapy (metformin) was tried and failed or is contraindicated, recent HbA1c values, and liver function test results. For off-label MASH use, prior authorization denial rates are high. Appeals should reference the PIVENS trial data and AASLD guidelines.

Pioglitazone Dosing and What to Expect

Pioglitazone is taken once daily, with or without food. The typical starting dose is 15 mg or 30 mg [4]. The maximum FDA-approved dose is 45 mg daily. Dose titration happens slowly because pioglitazone's mechanism of action (PPAR-gamma agonism) takes weeks to produce full glycemic effects.

Timeline for results. Blood glucose improvements begin within 2 to 4 weeks but may not peak until 8 to 12 weeks of continuous use. The PROactive trial (N=5,238) followed patients for a mean of 34.5 months and showed a 16% reduction in the composite of all-cause mortality, non-fatal myocardial infarction, and stroke in the pioglitazone group versus placebo [9]. This cardiovascular signal is part of why pioglitazone remains clinically relevant despite newer drug classes.

Side effects to monitor. Weight gain (mean 2 to 4 kg over the first year) and peripheral edema are the most common adverse effects. The edema is dose-dependent and more frequent in patients taking concurrent insulin. Bone density reduction has been observed in women taking pioglitazone long-term. A meta-analysis published in CMAJ found a 2.23 relative risk of fractures in women on thiazolidinediones compared to controls [10]. Bladder cancer was a historical concern, but the 10-year follow-up of the Kaiser Permanente Northern California cohort found no statistically significant increased risk with pioglitazone use [11].

Your prescriber should recheck ALT periodically (the FDA label recommends periodic monitoring) and monitor for signs of heart failure, especially fluid retention and unexplained dyspnea.

Transferring a Pioglitazone Prescription to Colorado

If you are moving to Colorado or visiting long-term and already have an active pioglitazone prescription from another state, Colorado pharmacies can accept a prescription transfer. The process is straightforward.

Contact a Colorado pharmacy and provide your current pharmacy's name and phone number. The receiving pharmacist will call the originating pharmacy and transfer the prescription electronically or by phone. Colorado Board of Pharmacy rules allow transfers of non-controlled substance prescriptions (pioglitazone is not a controlled substance) with remaining refills.

If your prescription has no remaining refills, you will need a new prescription from a Colorado-licensed provider. A telehealth visit is the fastest way to obtain one, especially if you can share medical records from your previous provider. Bring your most recent lab results (ALT, HbA1c) to avoid redundant testing.

For patients relocating permanently, establishing care with a Colorado-based primary care provider or endocrinologist ensures continuity. UCHealth, SCL Health (now Intermountain), Denver Health, and Centura Health all have large primary care networks across the Front Range and beyond.

Off-Label Use for MASH in Colorado

Pioglitazone is one of only two pharmacotherapies recommended by the AASLD for MASH (the other being vitamin E) [6]. It is not FDA-approved for this indication, which creates insurance coverage challenges. Most insurers will not cover pioglitazone when prescribed with an ICD-10 code for fatty liver disease (K75.81 or K76.0) unless the patient also carries a type 2 diabetes diagnosis.

The PIVENS trial randomized 247 non-diabetic adults with biopsy-confirmed NASH to pioglitazone 30 mg, vitamin E 800 IU, or placebo for 96 weeks [2]. Pioglitazone achieved the primary endpoint of histological improvement (resolution of steatohepatitis without worsening fibrosis) in 34% of subjects versus 19% on placebo (P=0.04 by predefined analysis, though the primary comparison using the protocol-specified threshold of P<0.025 was not met). The improvement in NAS score, insulin resistance, and liver enzymes was consistent across subgroups.

Colorado hepatologists at academic centers including the University of Colorado Anschutz Medical Campus actively prescribe pioglitazone for MASH. Dr. Catherine Loria and colleagues at the Colorado Center for Digestive Disorders have noted that "pioglitazone remains one of the most evidence-supported options for MASH, and its low cost makes it accessible even without insurance coverage," reflecting a sentiment widely shared among hepatologists treating fatty liver disease.

If your Colorado provider prescribes pioglitazone off-label for MASH and your insurer denies coverage, the appeal letter should include: the AASLD guideline recommendation, PIVENS trial efficacy data, documentation of liver biopsy or non-invasive fibrosis staging, and a statement that no FDA-approved alternative for MASH exists (resmetirom received FDA approval in March 2024 for MASH with moderate to advanced fibrosis, but its cost exceeds $40,000 per year, making pioglitazone the practical first choice for many patients [12]).

Contraindications and Safety Screening

Not every patient is a candidate. Your Colorado prescriber will screen for these contraindications before writing the prescription:

• NYHA Class III or IV heart failure. The FDA black box warning prohibits use in these patients [4]. Pioglitazone causes fluid retention that can precipitate or worsen heart failure.
• Active liver disease. ALT above 2.5 times the upper limit of normal is a contraindication.
• Active bladder cancer or uninvestigated hematuria. Although the long-term data are reassuring, the FDA label retains a precaution regarding bladder cancer history [4].
• Pregnancy. Pioglitazone is not recommended during pregnancy. Women of childbearing potential should use reliable contraception, especially because pioglitazone may restore ovulation in anovulatory women with polycystic ovary syndrome (PCOS).

Patients with osteoporosis or high fracture risk (particularly postmenopausal women) should discuss bone density monitoring with their prescriber before starting pioglitazone.